Type III secretion systems and disease

Clinical Microbiology Reviews

Volumn 20, Issue 4, 2007, Pages 535-549

  Coburn, Bryan ^a   Sekirov, Inna ^a   Finlay, B Brett ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN DERIVATIVE;

ANTIGEN RECOGNITION; AUTOPHAGY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL MIGRATION; CYTOTOXICITY; EFFECTOR CELL; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; REVIEW; TYPE III SECRETION SYSTEM;

ANIMALS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICE; VIRULENCE FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 35448975718     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00013-07     Document Type: Review

References (171)

1. Abrahams, G. L., P. Muller, and M. Hensel. 2006. Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole. Traffic 7:950-965.
2. Aepfelbacher, M. 2004. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia. Rev. Physiol. Biochem. Pharmacol. 152:65-77.
3. Alto, N. M., F. Shao, C. Lazar, R. Brost, G. Chua, S. Mattoo, S. McMahon, P. Ghosh, T. Hughes, C. Boone, and J. Dixon. 2006. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124:133-145.
4. Arbibe, L., D. Kim, E. Batsche, T. Pedron, B. Mateescu, C. Muchardt, C. Parsot, and P. Sansonetti. 2007. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 8:47-56.
5. Bertelsen, L., G. Paesold, S. Marcus, B. Finlay, L. Eckmann, and K. Barrett. 2004. Modulation of chloride secretory responses and barrier function of intestinal epithelial cells by the Salmonella effector protein SigD. Am. J. Physiol. Cell Physiol. 287:C939-C948.
6. Bhattacharjee, R., K. Park, Y. Kumagai, K. Okada, M. Yamamoto, S. Uematsu, K. Matsui, H. Kumar, T. Kawai, T. Iida, T. Honda, O. Takeuchi, and S. Akira. 2006. VP1686, a Vibrio type III secretion protein, induces Toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J. Biol. Chem. 281:36897-36904.
7. Birmingham, C., A. Smith, M. Bakowski, T. Yoshimori, and J. Brumell. 2006. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281:11374-11383.
8. Boucrot, E., T. Henry, J. Borg, J. Gorvel, and S. Meresse. 2005. The intracellular fate of Salmonella depends on the recruitment of kinesin. Science 308:1174-1178.
9. Bourdet-Sicard, R., M. Rudiger, B. Jockusch, P. Gounon, P. Sansonetti, and G. Nhieu. 1999. Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 18:5853-5862.
10. Boyle, E., N. Brown, and B. Finlay. 2006. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 8:1946-1957.
11. 11. Campellone, K. G., D. Robbins, and J. M. Leong. 2004. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-indepcndent actin assembly. Dev. Cell 7:217-228.
12. Campellone, K., and J. Leong. 2005. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogcnic Escherichia coli Tir. Mol. Microbiol. 56:416-432.
13. Campellone, K., S. Rankin, T. Pawson, M. Kirschner, D. Tipper, and J. Leong. 2004. Clustering of Nek by a 12-residue Tir phosphopeptide is sufficient to trigger localized actin assembly. J. Cell Biol. 164:407-415.
14. Caron, E., V. F. Crepin, N. Simpson, S. Knutton, J. Garmendia, and G. Frankel. 2006. Subversion of actin dynamics by EPEC and EHEC. Curr. Opin. Microbiol. 9:40-45.
15. Celli, J., M. Olivier, and B. Finlay. 2001. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20:1245-1258.
16. Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195:1155-1166.
17. Chang, J., J. Chen, and D. Zhou. 2005. Delineation and characterization of the actin nucleation and effector translocation activities of Salmonella SipC. Mol. Microbiol. 55:1379-1389.
18. Chen, H., and D. Schifferli. 2000. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar Typhimurium vaccine strains. Infect. Immun. 68:3129-3139.
19. Coburn, B., Y. Li, D. Owen, B. A. Vallance, and B. B. Finlay. 2005. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73:3219-3227.
20. Coombes, B. K., B. A. Coburn, A. A. Potter, S. Gomis, K. Mirakhur, Y. Li, and B. B. Finlay. 2005. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73:7161-7169.
21. Coster, T. S., C. W. Hoge, L. VanDeVerg, A. B. Hartman, E. V. Oaks, M. M. Venkatesan, D. Cohen, G. Robin, A. Fontaine-Thompson, P. J. Sansonetti, and T. Hale. 1999. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 67:3437-3443.
22. Dalsgaard, A., O. Serichantalergs, A. Forslund, W. Lin, J. Mekalanos, E. Mintz, T. Shimada, and J. Wells. 2001. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J. Clin. Microbiol. 39:4086-4092.
23. Dean, P., and B. Kenny. 2004. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54:665-675.
24. Dengjel, J., O. Schoor, R. Fischer, M. Reich, M. Kraus, M. Muller, K. Kreymborg, F. Altenberend, J. Brandenburg, H. Kalbacher, R. Brock, C. Driessen, H. G. Rammensee, and S. Stevanovic. 2005. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102:7922-7927.
25. Dziejman, M., D. Serruto, V. C. Tam, D. Sturtevant, P. Diraphat, S. M. Faruque, M. H. Rahman, J. F. Heidelberg, J. Decker, L. Li, K. T. Montgomery, G. Grills, R. Kucherlapati, and J. Mekalanos. 2005. Genomic characterization of non-O1, non-O139 Vibrio cholcrae reveals genes for a type III secretion system. Proc. Natl. Acad. Sci. USA 102:3465-3470.
26. Epelman, S., D. Stack, C. Bell, E. Wong, G. G. Neely, S. Krutzik, K. Miyake, P. Kubes, L. D. Zbytnuik, L. L. Ma, X. Xie, D. E. Woods, and C. H. Mody. 2004. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol. 173:2031-2040.
27. Espina, M., A. J. Olive, R. Kenjale, D. S. Moore, S. F. Ausar, R. W. Kaminski, E. V. Oaks, C. R. Middaugh, W. D. Picking, and W. Picking. 2006. IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect. Immun. 74:4391-4400.
28. Fernandez-Prada, C. M., D. L. Hoover, B. D. Tall, A. Hartman, J. Kopelowitz, and M. Venkatesan. 2000. Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages. Infect. Immun. 68:3608-3619.
29. Finck-Barbancon, V., and D. W. Frank. 2001. Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU. J. Bacteriol. 183:4330-4344.
30. Finck-Barbancon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
31. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, E. P. Grant, and G. Nunez. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and intcrleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7:576-582.
32. Frank, D. W., A. Vallis, J. Wiener-Kronish, A. Roy-Burman, E. Spack, B. Mullaney, M. Megdoud, J. Marks, R. Fritz, and T. Sawa. 2002. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J. Infect. Dis. 186:64-73.
33. Frankel, G., A. Phillips, L. Trabulsi, S. Knutton, G. Dougan, and S. Matthews. 2001. Intimin and the host cell - is it bound to end in Tir(s)? Trends Microbiol. 9:214-218.
34. Fu, Y., and J. E. Galan. 1999. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401:293-297.
35. Gal, D., M. Mayo, E. Spencer, A. Cheng, and B. Currie. 2005. Short report: application of a polymerase chain reaction to detect Burkholderia pseudomallei in clinical specimens from patients with suspected melioidosis. Am. J. Trop. Med. Hyg. 73:1162-1164.
36. Gallois, A., J. Klein, L. Allen, B. Jones, and W. Nauseef. 2001. Salmonella pathogenicity island 2-encoded type 111 secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166:5741-5748.
37. Garmendia, J., A. Phillips, M. Carlier, Y. Chong, S. Schuller, O. Marches, S. Dahan, E. Oswald, R. Shaw, S. Knutton, and G. Frankel. 2004. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type 111 effector protein that couples Tir to the actin-cytoskeleton. Cell. Microbiol. 6:1167-1183.
38. Gauthier, A., M. Robertson, M. Lowden, J. Ibarra, J. Puente, and B. Finlay. 2005. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob. Agents Chemother. 49:4101-4109.
39. Gewirtz, A. T., P. O. Simon, Jr., C. K. Schmitt, L. J. Taylor, C. H. Hagedorn, A. D. O'Brien, A. S. Neish, and J. L. Madara. 2001. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J. Clin. Investig. 107:99-109.
40. Ghosh, P. 2004. Process of protein transport by the type III secretion system. Microbiol. Mol. Biol. Rev. 68:771-795.
41. Gomez, H. F., I. Herrera-Insua, M. M. Siddiqui, V. A. Diaz-Gonzalez, E. Caceres, D. S. Newburg, and T. G. Cleary. 2001. Protective role of human lactoferrin against invasion of Shigella flexneri M90T. Adv. Exp. Med. Biol. 501:457-467.
42. Gomez, H. F., T. J. Ochoa, L. G. Carlin, and T. G. Cleary. 2003. Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Dis. 187:87-95.
43. Goure, J., P. Broz, O. Attree, G. Cornells, and I. Attree. 2005. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J. Infect. Dis. 192:218-225.
44. Gruenheid, S., and B. Finlay. 2003. Microbial pathogenesis and cytoskeletal function. Nature 422:775-781.
45. Guttman, J. A., F. N. Samji, Y. Li, W. Deng, A. Lin, and B. B. Finlay. 2007. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell. Microbiol. 9:131-141.
46. Guttman, J. A., Y. Li, M. Wickham, W. Deng, A. Vogl, and B. Finlay. 2006. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell. Microbiol. 8:634-645.
47. Hapfelmeier, S., B. Stecher, M. Barthel, M. Kremer, A. J. Muller, M. Heikenwalder, T. Stallmach, M. Hensel, K. Pfeffer, S. Akira, and W. D. Hardt. 2005. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J. Immunol. 174:1675-1685.
48. Hardt, W. D., L. M. Chen, K. E. Schuebel, X. R. Bustelo, and J. E. Galan. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826.
49. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Valles, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
50. Hauser, A. R., and S. Epelman. 1999. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells. Infect. Immun. 67:5530-5537.
51. Hayward, R. D., and V. Koronakis. 1999. Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J. 18:4926-4934.
52. Heath, D. G., G. J. Anderson, J. Mauro, S. Welkos, G. Andrews, J. Adamovicz, and A. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
53. Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. C. Fang, and D. W. Holden. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30:163-174.
54. Hernandez, L. D., K. Hueffer, M. R. Wenk, and J. E. Galan. 2004. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304:1805-1807.
55. Hernandez, L. D., M. Pypaert, R. Flavell, and J. Galan. 2003. A Salmonella protein causes macrophage cell death by inducing autophagy. J. Cell Biol. 163:1123-1131.
56. Hersh, D., D. M. Monack, M. R. Smith, N. Ghori, S. Falkow, and A. Zychlinsky. 1999. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. USA 96:2396-2401.
57. High, N., J. Mounier, M. Prevost, and P. Sansonetti. 1992. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11:1991-1999.
58. Hilbi, H. 1999. Host responses to secreted Shigella virulence factors. Curr. Opin. Infect. Dis. 12:221-228.
59. Hilbi, H., J. E. Moss, D. Hersh, Y. Chen, J. Arondel, S. Banerjee, R. A. Flavell, J. Yuan, P. J. Sansonetti, and A. Zychlinsky. 1998. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273:32895-32900.
60. Hill, J., C. Copse, S. Leary, A. Stagg, E. Williamson, and R. Titball. 2003. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect. Immun. 71:2234-2238.
61. Hill, J., S. Leary, K. Griffin, E. Williamson, and R. Titball. 1997. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65:4476-4482.
62. Hindle, Z., S. Chatfield, J. Phillimore, M. Bentley, J. Johnson, C. Cosgrove, M. Ghaem-Maghami, A. Sexton, M. Khan, F. Brennan, P. Everest, T. Wu, D. Pickard, D. Holden, G. Dougan, G. Griffin, D. House, J. Santangelo, S. Khan, J. Shea, R. Feldman, and D. Lewis. 2002. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect. Immun. 70:3457-3467.
63. Ivanoff, B., M. Levine, and P. Lambert. 1994. Vaccination against typhoid fever: present status. Bull. W. H. O. 72:957-971.
64. Jepson, M. A., S. Pellegrin, L. Peto, D. Banbury, A. Leard, H. Mellor, and B. Kenny. 2003. Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. Cell. Microbiol. 5:773-783.
65. Jiang, X., O. Rossanese, N. Brown, S. Kujat-Choy, J. Galan, B. Finlay, and J. Brumell. 2004. The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice. Mol. Microbiol. 54:1186-1198.
66. Karin, M., and Y. Ben Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
67. Katz, D. E., T. Coster, M. Wolf, F. Trespalacios, D. Cohen, G. Robins, A. Hartman, M. Venkatesan, D. Taylor, and T. Hale. 2004. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect. Immun. 72:923-930.
68. Kauppi, A. M., R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson. 2003. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10:241-249.
69. Kenny, B., S. Ellis, A. Leard, J. Warawa, H. Mellor, and M. Jepson. 2002. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol. Microbiol. 44:1095-1107.
70. Kerschen, E. J., D. A. Cohen, A. M. Kaplan, and S. C. Straley. 2004. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72:4589-4602.
71. Kim, D. W., G. Lenzen, A. L. Page, P. Legrain, P. J. Sansonetti, and C. Parsot. 2005. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 102:14046-14051.
72. Kirkpatrick, B., R. McKenzie, J. O'Neill, C. Larsson, A. Bourgeois, J. Shimko, M. Bentley, J. Makin, S. Chatfield, Z. Hindle, C. Fidler, B. Robinson, C. Ventrone, N. Bansal, C. Carpenter, D. Kutzko, S. Hamlet, C. LaPointe, and D. Taylor. 2006. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 24:116-123.
73. Knodler, L. A., and O. Steele-Mortimer. 2005. The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension. Mol. Biol. Cell 16:4108-4123.
74. Knodler, L., and O. Steele-Mortimer. 2003. Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 4:587-599.
75. Knutton, S., D. Lloyd, and A. McNeish. 1987. Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect. Immun. 55:69-77.
76. Kotloff, K. L., F. Noriega, T. Samandari, M. Sztein, G. Losonsky, J. Nataro, W. Picking, E. Barry, and M. M. Levine. 2000. Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect. Immun. 68:1034-1039.
77. Kotloff, K., F. Noriega, G. Losonsky, M. Sztein, S. Wasserman, J. Nataro, and M. Levine. 1996. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect. Immun. 64:4542-4548.
78. Kotloff, K., D. Taylor, M. Sztein, S. Wasserman, G. Losonsky, J. Nataro, M. Venkatesan, A. Hartman, W. Picking, D. Katz, J. Campbell, M. Levine, and T. Hale. 2002. Phase I evaluation of ΔvirG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults. Infect. Immun. 70:2016-2021.
79. Kotton, C., A. Lankowski, N. Scott, D. Sisul, L. Chen, K. Raschke, G. Borders, M. Boaz, A. Spentzou, J. Galan, and E. Hohmann. 2006. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella type III secretion system. Vaccine 24:6216-6224.
80. Kuhle, V., and M. Hensel. 2004. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2. Cell. Mol. Life Sci. 61:2812-2826.
81. Kuhle, V., G. Abrahams, and M. Hensel. 2006. Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner. Traffic 7:716-730.
82. Kuhle, V., D. Jackel, and M. Hensel. 2004. Effector proteins encoded by Salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells. Traffic 5:356-370.
83. Kuhle, V., and M. Hensel. 2002. SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments. Cell. Microbiol. 4:813-824.
84. La Ragione, R., S. Patel, B. Maddison, M. Woodward, A. Best, G. Whitelam, and K. Gough. 2006. Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro. Microbes Infect. 8:426-433.
85. Leary, S., K. Griffin, E. Galyov, J. Hewer, E. Williamson, A. Holmstrom, A. Forsberg, and R. Titball. 1999. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb. Pathog. 26:159-169.
86. Li, L., M. Ledizet, K. Kar, R. Koski, and B. Kazmierczak. 2005. An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of type III virulence phenotypes of Pseudomonas aeruginosa isolates. Ann. Clin. Microbiol. Antimicrob. 4:22.
87. Lugert, R., M. Kuhns, T. Polch, and U. Gross. 2004. Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med. Microbiol. Immunol. 193:163-171.
88. Luperchio, S., and D. B. Schauer. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3:333-340.
89. Lyons, S., L. Wang, J. E. Casanova, S. V. Sitaraman, D. Merlin, and A. T. Gewirtz. 2004. Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway. J. Cell Sci. 117:5771-5780.
90. Ma, C., M. Wickham, J. Guttman, W. Deng, J. Walker, K. Madsen, K. Jacobson, W. Vogl, B. Finlay, and B. Vallance. 2006. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell. Microbiol. 8:1669-1686.
91. Makino, K., K. Oshima, K. Kurokawa, K. Yokoyama, T. Uda, K. Tagomori, Y. Iijima, M. Najima, M. Nakano, A. Yamashita, Y. Kubota, S. Kimura, T. Yasunaga, T. Honda, H. Shinagawa, M. Hattori, and T. Iida. 2003. Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V. cholerae. Lancet 361:743-749.
92. Marcus, S., M. Wenk, O. Steele-Mortimer, and B. Finlay. 2001. A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation. FEBS Lett. 494:201-207.
93. Marketon, M. M., R. W. DePaolo, K. L. DeBord, B. Jabri, and O. Schneewind. 2005. Plague bacteria target immune cells during infection. Science 309:1739-1741.
94. Matson, J., K. Durick. D. Bradley, and M. Nilles. 2005. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol. 5:38.
95. McGhie, E., R. Hayward, and V. Koronakis. 2004. Control of actin turnover by a salmonella invasion protein. Mol. Cell 13:497-510.
96. Menard, R., M. Prevost, P. Gounon, P. Sansonetti, and C. Dehio. 1996. The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc. Natl. Acad. Sci. USA 93:1254-1258.
97. Meumann, E., R. Novak, D. Gal, M. Kaestli, M. Mayo, J. Hanson, E. Spencer, M. Glass, J. Gee, P. Wilkins, and B. Currie. 2006. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J. Clin. Microbiol. 44:3028-3030.
98. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin lbeta via Ipaf. Nat. Immunol. 7:569-575.
99. Miura, M., J. Terajima, H. Izumiya, J. Mitobe, T. Komano, and H. Watanabe. 2006. OspE2 of Shigella sonnei is required for the maintenance of cell architecture of bacterium-infected cells. Infect. Immun. 74:2587-2595.
100. Monack, D. M., J. Mecsas, N. Ghori, and S. Falkow. 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA 94:10385-10390.
101. Mueller, C., P. Broz, S. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn, A. Engel, and G. Cornelis. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310:674-676.
102. Mukherjee, S., G. Keitany, Y. Li, Y. Wang, H. Ball, E. Goldsmith, and K. Orth. 2006. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312:1211-1214.
103. Muschiol, S., L. Bailey, A. Gylfe, C. Sundin, K. Hultenby, S. Bergstrom, M. Elofsson, H. Wolf-Watz, S. Normark, and B. Henriques-Normark. 2006. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103:14566-14571.
104. Neely, A., I. Holder, J. Wiener-Kronish, and T. Sawa. 2005. Passive antiPcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. Burns 31:153-158.
105. Nishikawa, H., E. Sato, G. Briones, L. Chen, M. Matsuo, Y. Nagata, G. Ritter, E. Jager, H. Nomura, S. Kondo, I. Tawara, T. Kato, H. Shiku, L. Old, J. Galan, and S. Gnjatic. 2006. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J. Clin. Investig. 116:1946-1954.
106. Nordfelth, R., A. M. Kauppi, H. A. Norberg, H. Wolf-Watz, and M. Elofsson. 2005. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73:3104-3114.
107. Oaks, E., and K. Turbyfill. 2006. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Vaccine 24:2290-2301.
108. Ogawa, M., T. Yoshimori, T. Suzuki, H. Sagara, N. Mizushima, and C. Sasakawa. 2005. Escape of intracellular Shigella from autophagy. Science 307:727-731.
109. Ohya, K., Y. Handa, M. Ogawa, M. Suzuki, and C. Sasakawa. 2005. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 280:24022-24034.
110. Ono, T., K. Park, M. Ueta, T. Iida, and T. Honda. 2006. Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infect. Immun. 74:1032-1042.
111. Orr, N., D. Katz, J. Atsmon, P. Radu, M. Yavzori, T. Halperin, T. Sela, R. Kayouf, Z. Klein, R. Ambar, D. Cohen, M. Wolf, M. Venkatesan, and T. Hale. 2005. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect. Immun. 73:8027-8032.
112. Ou, T., J. Liu, and H. Leu. 2003. Independent prognostic factors for fatality in patients with invasive Vibrio cholerae non-O1 infections. J. Microbiol. Immunol. Infect. 36:117-122.
113. Panthel, K., K. Meinel, L. Sevil, V. Domenech, G. Geginat, K. Linkemann, D. Busch, and H. Russmann. 2006. Prophylactic anti-tumor immunity against a murine fibrosarcoma triggered by the Salmonella type III secretion system. Microbes Infect. 8:2539-2546.
114. Park, K., T. Ono, M. Rokuda, M. Jang, K. Okada, T. Iida, and T. Honda. 2004. Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect. Immun. 72:6659-6665.
115. Persson, C., R. Nordfelth, K. Andersson, A. Forsberg, H. Wolf-Watz, and M. Fallman. 1999. Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism. Mol. Microbiol. 33:828-838.
116. Phalipon, A., and P. J. Sansonetti. 2007. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol. Cell Biol. 85:119-129.
117. Phillips, N., R. Hayward, and V. Koronakis. 2004. Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation. Nat. Cell Biol. 6:618-625.
118. Potter, A., S. Klashinsky, Y. Li, E. Frey, H. Townsend, D. Rogan, G. Erickson, S. Hinkley, T. Klopfenstein, R. Moxley, D. Smith, and B. Finlay. 2004. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22:362-369.
119. Power, M. R., Y. Peng, E. Maydanski, J. S. Marshall, and T. J. Lin. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279:49315-49322.
120. Raffatellu, M., R. Wilson, D. Chessa, H. Andrews-Polymenis, Q. Tran, S. Lawhon, S. Khare, L. Adams, and A. Baumler. 2005. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype Typhimurium invasion of epithelial cells. Infect. Immun. 73:146-154.
121. Ridley, A. J. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16:522-529.
122. Rocha, C., J. Coburn, E. Rucks, and J. Olson. 2003. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect. Immun. 71:5296-5305.
123. Rosenberger, C., and B. Finlay. 2003. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat. Rev. Mol. Cell. Biol. 4:385-396.
124. Rosenberger, C., and B. Finlay. 2004. Bacterial responses to neutrophil phagocytosis. Curr. Opin. Hematol. 11:1-6.
125. Rosqvist, R., K. Magnussen, and H. Wolf-Watz. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972.
126. Roy-Burman, A., R. H. Savel, S. Racine, B. L. Swanson, N. S. Revadigar, J. Fujimoto, T. Sawa, D. W. Frank, and J. P. Wiener-Kronish. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
127. Ruckdeschel, K., O. Mannel, K. Richter, C. A. Jacobi, K. Trulzsch, B. Rouot, and J. Heesemann. 2001. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J. Immunol. 166:1823-1831.
128. Russmann, H., and K. Panthel. 2004. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming. Int. J. Med. Microbiol. 294:313-317.
129. Russmann, H. 2003. Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella. Int. J. Med. Microbiol. 293:107-112.
130. Sambri, V., M. Donati, E. Storni, K. Di Leo, M. Agnusdei, R. Petracca, O. Finco, G. Grandi, G. Ratti, and R. Cevenini. 2004. Experimental infection by Chlamydia pneumoniae in the hamster. Vaccine 22:1131-1137.
131. Sani, M., A. Botteaux, C. Parsot, P. Sansonetti, E. Boekema, and A. Allaoui. 2007. IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus. Biochim. Biophys. Acta 1770:307-311.
132. Sansonetti, P. J., A. Phalipon, J. Arondel, K. Thimmalai, S. Banerjee, S. Akira, K. Takeda, and A. Zychlinsky. 2000. Caspase-1 activation of IL-1beta and IL-18 arc essential for Shigella flexneri-induced inflammation. Immunity 12:581-590.
133. Sato, H., D. W. Frank, C. J. Hillard, J. B. Feix, R. R. Pankhaniya, K. Moriyama, V. Finck-Barbancon, A. Buchaklian, M. Lei, R. M. Long, J. Wiener-Kronish, and T. Sawa. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
134. Schlumberger, M., and W. Hardt. 2006. Salmonella type III secretion effectors: pulling the host cell's strings. Curr. Opin. Microbiol. 9:46-54.
135. Schotte, P., G. Denecker, B. A. Van Den, P. Vandenabeele, G. R. Cornells, and R. Beyaert. 2004. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J. Biol. Chem. 279:25134-25142.
136. Shao, F., P. Merritt, Z. Bao, R. Innes, and J. Dixon. 2002. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109:575-588.
137. Shea, J. E., M. Hensel, C. Gleeson, and D. W. Holden. 1996. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 93:2593-2597.
138. Shime, N., T. Sawa, J. Fujimoto, K. Faure, L. Allmond, T. Karaca, B. Swanson, E. Spack, and J. Wiener-Kronish. 2001. Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa. J. Immunol. 167:5880-5886.
139. Sing, A., D. Reithmeier-Rost, K. Granfors, J. Hill, A. Roggenkamp, and J. Heesemann. 2005. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. USA 102:16049-16054.
140. Suzuki, T., Y. Yoshikawa, H. Ashida, H. Iwai, T. Toyotome, H. Matsui, and C. Sasakawa. 2006. High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin. J. Immunol. 177:4709-4717.
141. Swanson, M. 2006. Autophagy: eating for good health. J. Immunol. 177:4945-4951.
142. Swietnicki, W., B. Powell, and J. Goodin. 2005. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr. Purif. 42:166-172.
143. Tafazoli, F., A. Holmstrom, A. Forsberg, and K. Magnussen. 2000. Apically exposed, tight junction-associated betal-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect. Immun. 68:5335-5343.
144. Tammiruusu, A., T. Penttila, R. Lahesmaa, M. Sarvas, M. Puolakkainen, and J. Vuola. 2007. Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. Vaccine 25:283-290.
145. Terebiznik, M., O. Vieira, S. Marcus, A. Slade, C. Yip, W. Trimble, T. Meyer, B. Finlay, and S. Grinstein. 2002. Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat. Cell Biol. 4:766-773.
146. Thorpe, C., L. Edwards, R. Snelgrove, O. Finco, A. Rae, G. Grandi, R. Guilio, and T. Hussell. 2007. Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection. Vaccine 25:2252-2260.
147. Tomson, F., V. Viswanathan, K. Kanack, R. Kanteti, K. Straub, M.
148. Tran Van Nhieu, G., E. Caron, A. Hall, and P. Sansonetti. 1999. IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 18:3249-3262.
149. Troisfontaines, P., and G. R. Cornells. 2005. Type III secretion: more systems than you think. Physiology (Bethesda) 20:326-339.
150. Trulzsch, K., T. Sporleder, E. I. Igwe, H. Russmann, and J. Heesemann. 2004. Contribution of the major secreted Yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72:5227-5234.
151. Tsukita, S., M. Funise, and M. Itoh. 1999. Structural and signalling molecules come together at tight junctions. Curr. Opin. Cell Biol. 11:628-633.
152. Tsukita, S., M. Funise, and M. Itoh. 2001. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell. Biol. 2:285-293.
153. Tu, X., I. Nisan, C. Yona, E. Hanski, and I. Rosenshine. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol. Microbiol. 47:595-606.
154. Turbyfill, K., A. Hartman, and E. Oaks. 2000. Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine. Infect. Immun. 68:6624-6632.
155. Van Donkersgoed, J., D. Hancock, D. Rogan, and A. Potter. 2005. Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan. Can. Vet. J. 46:724-728.
156. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. Holden, S. Lucia, M. Dinauer, P. Mastroeni, and F. Fang. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287:1655- 1658.
157. Viboud, G., and J. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59:69-89.
158. Viswanathan, V., A. Koutsouris, S. Lukic, M. Pilkinton, I. Simonovic, M. Simonovic, and G. Hecht. 2004. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect. Immun. 72:3218-3227.
159. Wickham, M., C. Lupp, A. Vazquez, M. Mascarenhas, B. Coburn, B. Coombes, M. Karmali, J. Puente, W. Deng, and B. B. Finlay. 2007. Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect. 9:400-407.
160. Worley, M., G. Nieman, K. Geddes, and F. Heffron. 2006. Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells. Proc. Natl. Acad. Sci. USA 103:17915-17920.
161. Yang, X., X. Qu, K. Wang, J. Zheng, L. Si, X. Dong, and Y. Wang. 2005. Construction of prophylactic human papillomavirus type 16 L1 capsid protein vaccine delivered by live attenuated Shigella flexneri strain sh42. Acta Biochim. Biophys. Sin. 37:743-750.
162. Yoshida, S., Y. Handa, T. Suzuki, M. Ogawa, M. Suzuki, A. Tamai, A. Abe, E. Katayama, and C. Sasakawa. 2006. Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science 314:985-989.
163. Yoshida, S., E. Katayama, A. Kuwae, H. Mimuro, T. Suzuki, and C. Sasakawa. 2002. Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J. 21:2923-2935.
164. Yu, X., J. Ruiz-Albert, K. Unsworth, S. Garvis, M. Liu, and D. Holden. 2002. SpiC is required for secretion of Salmonella pathogenicity island 2 type III secretion system proteins. Cell. Microbiol. 4:531-549.
165. Yu, Y., H. Zeng, S. Lyons, A. Carlson, D. Merlin, A. S. Neish, and A. T. Gewirtz. 2003. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 285:G282-G290.
166. Zeng, H., H. Wu, V. Sloane, R. Jones, Y. Yu, P. Lin, A. T. Gewirtz, and A. S. Neish. 2006. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G96-G108.
167. Zhang, S., R. Santos, R. Tsolis, S. Stender, W. Hardt, A. Baumler, and L. Adams. 2002. The Salmonella enterica serotype Typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect. Immun. 70:3843-3855.
168. Zhou, D., and J. Galan. 2001. Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect. 3:1293-1298.
169. Zhou, D., M. Mooseker, and J. Galán. 1999. Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 283:2092-2095.
170. Zychlinsky, A., C. Fitting, J. M. Cavaillon, and P. J. Sansonetti. 1994. Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J. Clin. Investig. 94:1328-1332.
171. Zychlinsky, A., M. C. Prevost, and P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169.